Future Mobility Campus Ireland (FMCI), a state-of-the-art mobility development centre and full-scale test bed, has announced that Caolan Bushell has been appointed as Non-Executive Chairman of the board.
Caolan will succeed Prof. Robert Shorten with effect from today with Robert standing down from the board and continuing his pioneering work with Imperial College, London.
Caolan has a successful executive career, in sales and business development, working globally in his day-to-day role at Mergon Group with world class OEMs in the automotive, industrial/renewables and medical device sectors including Tesla, Jaguar Land Rover, Abbott Diagnostics and Nexalus. He also has a distinguished record in working with leading industry groups and institutes including Irish Medtech Association, Irish Manufacturing Research (IMR), Dublin City University (DCU) and Advanced Materials and BioEngineering Research (AMBER).
His background in creating long lasting partnerships with some of the most innovative and disruptive companies in the world is ideally suited to supporting the executive team as they lead FMCI’s next phase of development.
Caolan Bushell, Non-Executive Chairman and VP Business Development at Mergon Group, commented:
Russell Vickers, Chief Executive Officer and Co-Founder of FMCI, commented: